Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older

Gynecologic Oncology

Volumn 145, Issue 3, 2017, Pages 526-530

  Driver, Jane A ^a,b,c   Viswanathan, Akila N ^b,c,d  

^a BOSTON MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Elderly; Endometrial cancer; Frailty; Radiation therapy

Indexed keywords

ALBUMIN; CARBOPLATIN; DOXORUBICIN; HEMOGLOBIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHARLSON COMORBIDITY INDEX; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; FRAILTY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY; WEIGHT REDUCTION; AGE; CANCER STAGING; ENDOMETRIAL NEOPLASMS; FRAIL ELDERLY; GERIATRIC ASSESSMENT; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 85016780938     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2017.03.010     Document Type: Article

References (26)

1. Lachance, J.A., Everett, E.N., Greer, B., Mandel, L., Swisher, E., Tamimi, H., et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol. Oncol. 101:3 (2006), 470–475.
2. Mundt, A.J., Waggoner, S., Yamada, D., Rotmensch, J., Connell, P.P., Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol. Oncol. 79:1 (2000), 79–85.
3. Alektiar, K.M., Venkatraman, E., Abu-Rustum, N., Barakat, R.R., Is endometrial carcinoma intrinsically more aggressive in elderly patients?. Cancer 98:11 (2003), 2368–2377.
4. Rauh-Hain, J.A., Pepin, K.J., Meyer, L.A., Clemmer, J.T., Lu, K.H., Rice, L.W., et al. Management for elderly women with advanced-stage, high-grade endometrial cancer. Obstet. Gynecol. 126:6 (2015), 1198–1206.
5. Clark, L.H., Jackson, A.L., Gehrig, P.A., Bae-Jump, V., Van Le, L., Ko, E.M., Adjuvant treatment and clinical trials in elderly patients with endometrial cancer: a time for change?. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 26:2 (2016), 282–289.
6. Creutzberg, C.L., van Putten, W.L., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Warlam-Rodenhuis, C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma. Lancet 355:9213 (2000), 1404–1411.
7. Fleming, N.D., Lentz, S.E., Cass, I., Li, A.J., Karlan, B.Y., Walsh, C.S., Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?. Gynecol. Oncol. 120:2 (2011), 189–192.
8. AlHilli, M.M., Bakkum-Gamez, J.N., Mariani, A., Weaver, A.L., McGree, M.E., Keeney, G.L., et al. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival. Gynecol. Oncol. 138:1 (2015), 133–140.
9. Fiorentino, A., Chiumento, C., Fusco, V., Do comorbidity influences acute toxicity and outcome in elderly patients with endometrial cancer treated by adjuvant radiotherapy plus brachytherapy?. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 15:8 (2013), 665–669.
10. Palaia, I., Loprete, E., Musella, A., Marchetti, C., Di Donato, V., Bellati, F., et al. Chemotherapy in elderly patients with gynecological cancer. Oncology 85:3 (2013), 168–172.
11. Zachariah, B., Balducci, L., Venkattaramanabalaji, G.V., Casey, L., Greenberg, H.M., DelRegato, J.A., Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int. J. Radiat. Oncol. Biol. Phys. 39:5 (1997), 1125–1129.
12. Clegg, A., Young, J., Iliffe, S., Rikkert, M.O., Rockwood, K., Frailty in elderly people. Lancet 381:9868 (2013), 752–762.
13. Hurria, A., Mohile, S., Gajra, A., Klepin, H., Muss, H., Chapman, A., et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 34:20 (2016), 2366–2371.
14. Hurria, A., Browner, I.S., Cohen, H.J., Denlinger, C.S., deShazo, M., Extermann, M., et al. Senior adult oncology. Journal of the National Comprehensive Cancer Network: JNCCN 10:2 (2012), 162–209.
15. Fega, K.R., Abel, G.A., Motyckova, G., Sherman, A.E., DeAngelo, D.J., Steensma, D.P., et al. Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults. Journal of Geriatric Oncology 6:4 (2015), 288–298.
16. Sherman, A.E., Motyckova, G., Fega, K.R., Deangelo, D.J., Abel, G.A., Steensma, D., et al. Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes. Leuk. Res. 37:9 (2013), 998–1003.
17. Hogberg, T., Signorelli, M., de Oliveira, C.F., Fossati, R., Lissoni, A.A., Sorbe, B., et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer—results from two randomised studies. Eur. J. Cancer 46:13 (2010), 2422–2431.
18. Greven, K., Winter, K., Underhill, K., Fontenesci, J., Cooper, J., Burke, T., Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol. Oncol. 103:1 (2006), 155–159.
19. Creutzberg, C.L., Nout, R.A., Lybeert, M.L., Warlam-Rodenhuis, C.C., Jobsen, J.J., Mens, J.W., et al. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 81:4 (2011), e631–e638.
20. Keys, H.M., Roberts, J.A., Brunetto, V.L., Zaino, R.J., Spirtos, N.M., Bloss, J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92:3 (2004), 744–751.
21. Viswanathan, A.N., Macklin, E.A., Berkowitz, R., Matulonis, U., The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol. Oncol. 123:3 (2011), 542–547.
22. Cancer Genome Atlas Research, N., Kandoth, C., Schultz, N., Cherniack, A.D., Akbani, R., Liu, Y., et al. Integrated genomic characterization of endometrial carcinoma. Nature 497:7447 (2013), 67–73.
23. Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56:3 (2001), M146–M156.
24. Searle, S.D., Mitnitski, A., Gahbauer, E.A., Gill, T.M., Rockwood, K., A standard procedure for creating a frailty index. BMC Geriatr., 8, 2008, 24.
25. Cohen, H.J., Smith, D., Sun, C.L., Tew, W.P., Mohile, S., Owusu, C., et al. Frailty as determined by a comprehensive geriatric assessment-derived deficit accumulation index in older patients with cancer who receive chemotherapy. Cancer, 000(000), 2016, 000.
26. Sur, M.D., Namm, J.P., Hemmerich, J.A., Buschmann, M.M., Roggin, K.K., Dale, W., Radiographic sarcopenia and self-reported exhaustion independently predict NSQIP serious complications after pancreaticoduodenectomy in older adults. Ann. Surg. Oncol. 22:12 (2015), 3897–3904.